Nanobiotix (Nasdaq: NBTX) reports June 2026 voting rights totals
Rhea-AI Filing Summary
Nanobiotix S.A. reported its share capital and voting rights position as of June 30, 2026, showing 50,825,682 shares outstanding.
The company reported 54,486,890 theoretical voting rights, used as the basis for calculating threshold crossings, and 54,464,772 exercisable voting rights, which exclude shares held in treasury where voting rights are suspended. Nanobiotix is a late-stage clinical biotechnology company headquartered in Paris and listed on Euronext Paris and the Nasdaq Global Select Market.
Positive
- None.
Negative
- None.
Key Figures
Shares outstanding: 50,825,682 shares
Theoretical voting rights: 54,486,890 voting rights
Exercisable voting rights: 54,464,772 voting rights
+3 more
6 metrics
Shares outstanding
50,825,682 shares
As of June 30, 2026
Theoretical voting rights
54,486,890 voting rights
Gross voting rights as of June 30, 2026
Exercisable voting rights
54,464,772 voting rights
Net voting rights as of June 30, 2026
Patent families
More than 30
Patent families across three nanotechnology platforms
Nanotechnology platforms
3 platforms
Applications in oncology, bioavailability and biodistribution, CNS disorders
Year of incorporation
2003
Year Nanobiotix was incorporated
Key Terms
theoretical voting rights, exercisable voting rights, threshold crossings, treasury, +1 more
5 terms
theoretical voting rights financial
"The total number of theoretical (or “gross”) voting rights is used"
Theoretical voting rights are the share of control an investor would have if all possible sources of additional shares—such as stock options, warrants and convertible bonds—were turned into ordinary shares. Investors care because this “what-if” number shows potential dilution of current owners and the maximum voting power others could gain, helping assess control risk and how future actions might change company decisions, like a snapshot of ownership if every coupon were cashed in.
exercisable voting rights financial
"The total number of exercisable at a shareholders’ meeting (or “net”) voting rights"
Exercisable voting rights are the actual, usable votes attached to a security or position that allow the holder to influence company decisions at shareholder meetings—for example electing the board or approving mergers. They matter to investors because the number of votes someone can cast determines who controls the company and its strategy, similar to having usable tickets at a town meeting rather than placeholders, and can affect share value, takeover risk and how much influence minority holders have.
threshold crossings financial
"used as the basis for calculating threshold crossings"
treasury financial
"without taking into account shares for which voting rights have been suspended as shares held in treasury"
The treasury is the department or area within a government or organization responsible for managing its money, finances, and financial strategies. It handles tasks like collecting revenue, paying bills, and planning for future financial needs, much like a household manages its budget. For investors, understanding the treasury is important because it influences interest rates, government spending, and overall economic stability.
nanotechnology platforms technical
"associated with three (3) nanotechnology platforms with applications in 1) oncology"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
How many voting rights does Nanobiotix (NBTX) have on a theoretical basis?
Nanobiotix reported 54,486,890 theoretical voting rights as of June 30, 2026. This gross figure includes all shares with attached voting rights, even those where voting rights are suspended, and is used to calculate regulatory threshold crossings.
What are Nanobiotix (NBTX) exercisable voting rights as of June 30, 2026?
Exercisable voting rights totaled 54,464,772 as of June 30, 2026. This net number excludes treasury shares for which voting rights are suspended and represents voting rights that can actually be exercised at a shareholders’ meeting.
On which markets is Nanobiotix (NBTX) listed?
Nanobiotix is listed on Euronext Paris and the Nasdaq Global Select Market. The company has been listed in Paris since 2012 and on Nasdaq in New York City since December 2020, giving it access to European and U.S. capital markets.
What kind of company is Nanobiotix (NBTX) and where is it based?
Nanobiotix is a late-stage clinical biotechnology company headquartered in Paris, France. Incorporated in 2003, it develops physics-based therapeutic approaches and holds more than 30 patent families across three nanotechnology platforms, including applications in oncology.